Effectiveness of mRNA Vaccines Against SARS-CoV-2 and Severe COVID-19 During Delta Variant Predominance in Italy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
BMJ: British Medical Journal
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Effectiveness of mRNA vaccines and waning of protection against SARS-CoV-2 infection and severe covid-19 during predominant circulation of the delta variant in Italy: retrospective cohort study
BMJ 2022 Feb 10;376(xx)e069052, M Fabiani, M Puopolo, C Morciano, M Spuri, S Spila Alegiani, A Filia, F D'Ancona, M Del Manso, F Riccardo, M Tallon, V Proietti, C Sacco, M Massari, R Da Cas, A Mateo-Urdiales, A Siddu, S Battilomo, A Bella, AT Palamara, P Popoli, S Brusaferro, G Rezza, F Menniti Ippolito, P PezzottiFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.